期刊文献+

钼靶X线在亚洲女性乳腺癌筛查中的准确性评价 被引量:21

Accuracy evaluation of mammography in the breast cancer screening in Asian women: a commtmitybased follow-up study and meta analysis
原文传递
导出
摘要 目的评价在亚洲人群乳腺癌筛查中使用钼靶X线诊断乳腺癌的准确性。方法2002年3月至2007年9月,收集8718名常规体检的成都市社区女性的乳腺钼靶X线检查资料,分别以病理组织学结果和随访结果为最终诊断的金标准,计算钼靶X线诊断乳腺癌的敏感度和特异度。检索国内外有关钼靶X线用于亚洲女性一般人群乳腺癌筛查的研究,连同上述队列资料一起纳入Meta分析,计算合并敏感度、特异度及诊断比值比(DOR),并绘制综合受试者工作特征曲线(SROC),评价其诊断效能。结果基于成都社区的随访研究显示,钼靶X线诊断乳腺癌的敏感度为0.889(95%CI为0.741—0.970),特异度为0.991(95%CI为0.987—0.993)。Meta分析共纳入合格研究7个,共计研究对象223619人。纳入的研究具有异质性,按照随机效应模型(REM)计算出的合并敏感度为0.845(95%CI为0.821~0.870),特异度为0.930(95%CI为0.929~0.931),DOR为117.271(95%CI为65.060~211.412),SROC下面积为0.9144。结论钼靶X线在亚洲女性乳腺癌筛查中有较高的准确性。 Objective To evaluate the accuracy of mammography in breast cancer screening in Asian women. Methods 8718 community women in Chengdu were examined by mammography during the routine physical examination from Mar. 2002 to Sep. 2007. Pathological diagnosis and following up results were used as the gold standards for X-ray-positive and -negative findings. The sensitivity, specificity and diagnosis odds ratio were calculated as accuracy indexes. Large scale follow-up studies of breast cancer screening in community in Asian women were collected to evaluate the pooled accuracy of mammography. Diagnosis meta-analysis was conducted with Meta-Disc software to estimate the pooled sensitivity, specificity and DOR, and draw the summary receiver operating characteristic (SROC). Results The data of seven studies were included with a total of 223 619 women received mammography for screening breast cancer. The sensitivity (95% CI) and specificity (95% CI) of mammography of community-based follow-up study in Chengdu were 0. 889 (0.741-0.970) and 0.991 (0. 987-0.993 ), respectively. Referring to meta-analysis, random effects models were adopted clue to existed heterogeneity among studies. The pooled sensitivity, specificity, DOR with their 95% confidence intervals were 0.845 (0. 821-0.870), 0.930 (0.929-0.931) and 117. 271 (65. 060-211. 412), respectively. The Area Under the Curve (AUC) of SROC was 0. 9144. Conclusion Due to its high accuracy, mammography deserves to be recommend in breast cancer screening in Asian women.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2010年第3期212-216,共5页 Chinese Journal of Oncology
关键词 乳房X线摄影术 乳腺肿瘤 普查 META分析 亚洲大陆世系人群 Mammography Breast neoplasms Mass screening Meta-analysis Asian continental ancestry group
  • 相关文献

参考文献17

  • 1Howard M,Agarwal G,Lytwyn A.Accuracy of self-reports of Pap and mammography screening compared to medical record:a metaanalysis.Cancer Causes Control,2009,20:1-13.
  • 2董志伟,乔友林,李连弟,陈育德,王润田,雷通海,饶克勤,王汝宽,赵平,游伟程,鲁凤珠,戴旭东,王国清,罗贤懋,周海城.中国癌症控制策略研究报告[J].中国肿瘤,2002,11(5):250-260. 被引量:350
  • 3何健荣,高曦,任泽舫.全球女性乳腺癌和卵巢癌最新发病分布特征[J].中国肿瘤,2009,18(3):169-172. 被引量:63
  • 4Lee SY,Jeong SH,Kim YN,et al.Cost-effective mammography screening in Korea:high incidence of breast cancer in young women.Cancer Sei,2009,100:1105-1111.
  • 5Wong IO,Kuntz KM,Cowling BJ.Cost effectiveness of manmography screening for Chinese women.Cancer,2007,110:885-895.
  • 6Moss S.Screening for breast Cancer in India:ia it an appropriate strategy?J Natl Cancer Inst,2008,100:1270-1271.
  • 7Leung GM,Lan TH,Thach TQ,et al.Will screening manmogrphy in the East do more harm than good? Am J Public Health,2002,92:1841-1846.
  • 8Gatsonis C,Macaskin P.The Cochrane methods group on systematic review of screening and diagnostic tests:recommended methods[2005-10-17].http.//www.cochrane.org/docs/sadtdoel.htm.
  • 9Morimoto T,Sasa M,Yamaquehi T,et aL.Effeetiveness of mammographic screening for breast cancer in women aged over 50 years in Japan.Jpn J Cancer Res,1997,88:778-784.
  • 10Kerlikowske K,Creasman J,Leunq JW,et al.Differences in screening mammography outcomes among White,Chinese,and Filipino women.Areh Intern Med,2005,165:1862-1868.

二级参考文献17

  • 1鲍萍萍,郑莹,李新建,沈玉珍,向詠梅,金凡.利用GM模型分析上海市区女性乳腺癌和卵巢癌发病率[J].中国卫生统计,2005,22(5):299-300. 被引量:16
  • 2李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:227
  • 3Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world[J]. J Clin Oncol, 2006, 24(14):2137-2150.
  • 4Nkondjock A, Ghadirian P. Risk factors and risk reduction of breast cancer[J]. Med Sci (Paris), 2005, 21(2):175-180.
  • 5Salehi F, Dunfield L, Phillips KP, et al. Risk factors for ovarian cancer: an overview with emphasis on hormonal factors[J]. J Toxicol Environ Health B Crit Rev, 2008, 11 (3-4):301-321.
  • 6Vo C, Carney ME. Ovarian cancer hormonal and environmental risk effect[J]. Obstet Gynecol Clin North Am, 2007, 34(4):687-700.
  • 7Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. Vol.Ⅸ[M]. Lyon: IARC, 2007.
  • 8Lee JH, Yim SH, Won YJ, et al. Population-based breast cancer statistics in Korea during 1993-2002: incidence, mortality, and survival[J]. J Korean Med Sci, 2007, 22 (Suppl):S11-16.
  • 9Chung HH, Hwang SY, Jung KW, et al. Ovarian cancer incidence and survival in Korea: 1993-2002[J]. Int J Gynecol Cancer, 2007, 17(3):595-600.
  • 10Marshall M, Solomon S. Hereditary breast-ovarian cancer: clinical findings and medical management [J]. Plast Surg Nurs, 2007, 27(3):124-127.

共引文献520

同被引文献232

引证文献21

二级引证文献289

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部